American Heart Journal

Article	Citations
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	118
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	99
Information for Readers	90
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	82
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	77
Table of Contents	66
Response to letters-to-the-editor for publication: “Defect-free care trends in the Paul Coverdell National Acute Stroke Program (PCNASP), 2008-2018. American Heart Journal. 2021;232:177-184. doi:10.10	64
Information for Readers	63
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	62
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	59
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging	58
Physician responses to apple watch-detected irregular rhythm alerts	57
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	45
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial	45
Editorial Board	41
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	41
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	39
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	38
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	37
Table of Contents	36
The trial to assess chelation therapy 2 (TACT2): Rationale and design	34
Table of Contents	33
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	32
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison	32
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	30

Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	30
Accuracy of Instantaneous Wave-free Ratio and Fractional Flow Reserve Derived From Single Coronary Angiographic Projections	30
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	30
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	29
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	27
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	27
The “Great Wave”: Childhood Obesity and Overweight	26
Ambulatory inotropic therapy: To what end?	26
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	26
Editorial Board	25
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	24
Table of Contents	24
Editorial Board	23
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	23
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	23
Information for Readers	23
Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial	22
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	22
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	22
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	22
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	21
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	21
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	21
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	21
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	21
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	21
Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network: Rationale and Design of the Monitor-BP Cluster Randomized Trial	21
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	20
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	20
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and prese	20
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	20
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	20
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	20
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	19
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	19
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	19
Perioperative bleeding and outcomes after noncardiac surgery	18
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	18
Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study	18
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial	18
Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	17
ISCHEMIA-EXTEND studies: Rationale and design	17
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	17
Renin–angiotensin–aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system	17
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	17
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	17
Information for Readers	16
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	16
High Glucose Suppresses Cardiomyocyte Progenitor Cell Regenerative Capacity and the Role of miR-195/EZH2 Crosstalk in Gestational Diabetes Mellitus	16
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	16

Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	16
Tricuspid valve disease prevalence and the impact of tricuspid valve surgery on cardiovascular events and hospital resource use in medicare beneficiaries	16
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	16
Editorial Board	16
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	16
Hypocholesterolemic Effect of Avocado (Persea americana Mill) Juice in Hypercolestrolemic Rats Model	16
Editorial Board	16
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	15
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study	15
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	15
Electronic health record risk score provides earlier prognostication of clinical outcomes in patients admitted to the cardiac intensive care unit	15
Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials	15
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Type 1 diabetes and oxidative stress markers	15
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	15
The Relationship Between Glycemia and Heart Failure in Patients with Coronary Heart Disease and Diabetes Mellitus 2	14
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	14
Information for Readers	14
Table of Contents	14
Influence of Prediabetes on Coronary Atherosclerotic Plaque Burden Assessed by Coronary Computed Tomography Angiography (CCTA).	14
Association of change in QRS duration with chronic heart failure outcomes	14
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	13
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	13
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	13
Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial	13
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	13
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	13
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	13
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	13
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	13
Information for Readers	13
Editorial Board	13
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	13
Periodontal Disease, Atrial Fibrillation and Stroke	13
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	13
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	12
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	12
Editorial Board	12
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of	12
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	12
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	12
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	12
Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is ‘paroxysmal’ atrial fibrillation?	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers a	12
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	12
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	12
Table of Contents	12
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	12
Editorial Board	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	11
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	11
Table of Contents	11
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	11
Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure	11
Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients	11
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy	11
Computerized technologies informing cardiac catheterization and guiding coronary intervention	11
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	11
Coarctation of aorta is associated with left ventricular stiffness, left atrial dysfunction and pulmonary hypertension	11
Association of Testosterone-Induced Increase in Neutrophil and Monocyte Counts with Thromboembolic Events: The TRAVERSE Trial	11
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics	11
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	11
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	11
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	11
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	11
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	11
Dysglycemia and incident heart failure among blacks: The jackson heart study	11
Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes	10
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	10
Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices	10
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
Table of Contents	10
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	10
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	10
Editorial Board	10
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	10
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	10

Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	10
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	10
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	10
OCEAN trial update	10
Information for Readers	10
Patients Admitted with Metabolic Syndrome and Atrial Fibrillation Have Greater Risk of Adverse Cardiovascular Events and Clinical Outcomes	10
Editorial Board	9
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	9
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	9
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	9
Financial burden, distress, and toxicity in cardiovascular disease	9
Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis	9
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	9
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	9
EVALUATION OF NEUTROPHIL-LYMPHOCYTE RATIO IN DIABETES AND CORONARY ARTERY DISEASE: A CASE CONTROL STUDY FROM INDIA	9
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial	9
Editorial Board	9
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	9
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	9
Table of Contents	9
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	9
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	9
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	9
Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)	9
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	9
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design	9
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	9
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	9
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	9
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	9
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	9
Information for Readers	8
Editorial Board	8
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	8
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	8
Editorial Board	8
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	8
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	8
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	8
Editorial Board	8
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	8
Impact of targeted pulmonary arterial hypertension therapy in patients with combined post- and precapillary pulmonary hypertension	8
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	8
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	8
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial	8
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	8
Table of Contents	8
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	8
Ambulatory management of cardiac amyloidosis	8
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	8
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study	8
Prevalence and clinical correlates and characteristics of “Super Fontan”	7
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	7
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	7
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	7
Information for Readers	7
Nigella sativa for the management of hyperglycaemia and dyslipidemia	7
Table of Contents	7
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	7
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	7
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study	7
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	7
Hemodialysis and its impact on patient characteristics, microbiology, cardiac surgery, and mortality in infective endocarditis	7
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	7
Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial	7
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	7
The pathophysiology of patent foramen ovale and its related complications	7
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	7
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	7
Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study	7
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease	6
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design	6
Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry	6
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)	6
Enrollment strategies in the era of digital revolution: Experience from a remote health management program	6
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a nonhigh-sensitivity troponin T assay after noncardiac surgery	6
Microalbuminuria in Patients with Type 2 Diabetes Mellitus Treated with a Phytoformula as Adjuvant.	6
A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial	6
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary	6
A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia	6
To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies	6
Effectiveness of the risk stratification proposed by the 2022 European Heart Rhythm Association Expert Consensus statement on arrhythmic mitral valve prolapse	6
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)	6
Obicetrapib Demonstrates Significant Deductions of LP(A) on Top of High-Intensity Statins	6
Design and rationale of the mobile health intervention for rural atrial fibrillation	6
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	6
The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design	6
at onal anish endocarditis st die – Design and objectives of the NIDUS registry	6
Could paramedics use the HEART Pathway to identify patients at low-risk of myocardial infarction in the prehospital setting?	6
Validation of the ARIC prediction model for sudden cardiac death in the European population: The ESCAPE-NET project	6